Amritpal Anand, MD
Rheumatology · Elgin, ILNPI 1770701716
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.8% of the total across 242 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AbbVie at 34.3% of the total. Reporting peaked in 2021 at $1,926 and has fallen 77.4% since, to $435 in 2025.
Across 242 payments — averaging $23.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Amgen$931
- Johnson & Johnson$610
- AstraZeneca$325
- Pacira Therapeutics, Inc.$266
- UCB, Inc.$241
- plus $1K from 19 others
Across 2 payments — averaging $17,299 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$35K
What the payments were for
- Consulting fees$200%
- Food & beverage$5,43295%
- Education$2805%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 92 | $1,963 |
| Amgen(2 entities) | 39 | $931 |
| Johnson & Johnson(3 entities) | 24 | $610 |
| AstraZeneca(2 entities) | 9 | $325 |
| Pacira Therapeutics, Inc. | 7 | $266 |
| UCB, Inc. | 12 | $241 |
| Novartis | 8 | $185 |
| Boehringer Ingelheim | 3 | $163 |
| Lilly USA, LLC | 8 | $156 |
| Pfizer | 7 | $142 |
| GSK | 7 | $123 |
| Janssen Scientific Affairs, LLC | 3 | $95 |
| Aurinia Pharma U.S., Inc. | 4 | $95 |
| Sanofi | 4 | $90 |
| Genentech USA, Inc. | 2 | $77 |
| Sanofi-aventis U.S. LLC | 1 | $53 |
| Shire North American Group Inc | 2 | $45 |
| E.r. Squibb & Sons, L.L.C. | 2 | $44 |
| Antares Pharma, Inc. | 2 | $30 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Mylan Institutional Inc. | 1 | $18 |
| Convatec Inc. | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
| Heraeus Medical, LLC. | 1 | $13 |
| KCI USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,732 in reported general payments places this provider in the 75th percentile of 287 rheumatology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 15 | $178,516 |
| Enbrel SureclickEtanercept | 16 | $114,784 |
| Xeljanz XrTofacitinib Citrate | 17 | $114,125 |
| Taltz AutoinjectorIxekizumab | 11 | $76,536 |
| Hydroxychloroquine Sulfate | 235 | $8,150 |
| Leflunomide | 121 | $7,305 |
| MethotrexateMethotrexate Sodium | 212 | $6,407 |
| Mycophenolate Mofetil | 24 | $3,302 |
| Celecoxib | 23 | $1,856 |
| Allopurinol | 69 | $946 |
| Colchicine | 12 | $936 |
| Famotidine | 29 | $793 |
| Gabapentin | 40 | $534 |
| Prednisone | 77 | $406 |
| Alendronate Sodium | 41 | $349 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Elgin
- Husna SiddiquiElgin$17K
- Manish JainChicago$1.9M
- Lori SiegelBannockburn$1.5M
- Alfonso BelloGlenview$611K
- Theodore PincusChicago$524K
- Angela CrowleyWillowbrook$483K
- Eric RudermanChicago$440K
- Anisha DuaChicago$280K
- Arthur MandelinChicago$270K
- Jeffrey HorvathSpringfield$246K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.